QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Spotlighted in Recent EIO Report from Crystal Research Associates
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a life-sciences holding company dedicated to building a portfolio of assets and biotech solutions, has announced the release of an executive informational overview(R) (“EIO”) from Crystal Research Associates LLC. The 58-page report reviews FSD Pharma’s drug-development pipeline and operational milestones. Crystal Research Associates has created a reputation for successfully reporting on small- and mid-cap companies to investors; the company has released previous reports on FSD Pharma’s performance. The most recent report features FSD’ Pharma’s major milestones, drug pipeline and overall operations. To view the full report, visit https://ibn.fm/dpUnE To view the full…